MDJ Consulting is a scientific management consultancy supporting the biotech and pharmaceutical industries, the life science venture capital industry and the technology transfer field. We provide services in the planning, execution, control and troubleshooting of scientific and technology projects and alliances. MDJ Consulting has delivered for its clients detailed project and research plans, functional capabilities and constraints analyses, project budgets and forecasts, project risk assessments, and other key project documents.

MDJ Consulting can offer your company proven expertise and experience in:

  • Scientific project planning and execution
  • Strategic alliances and collaborations
  • Project management
  • Troubleshooting, analysis and due diligence research
  • Development, writing and revision of key project documents
  • Technology transfer
  • Software and technical training development and delivery
  • Neuroscience, cell and molecular biology, apoptosis, and functional genomics

With over 14 years of academic and industry experience in the life sciences, MDJ Consulting builds upon an unusual combination of experience in neuroscience, drug discovery research, technology transfer project management and strategic alliances. We bring to our engagements a depth of understanding of both the biotech/pharmaceutical industry and academia, and a wide network of science and business contacts.

Michael Jacobsonhas an extensive scientific background in neuroscience, cell and molecular biology, apoptosis, drug target discovery and functional genomics. He received his B.S. cum laude in Biological Sciences from Cornell University, an M. Phil. in pharmacology from Cambridge University, U.K., a Ph.D. in neuroscience from U.C.S.F., and post-doctoral fellowship training at the MRC Laboratory for Molecular Cell Biology, London, U.K. He joined Millennium Pharmaceuticals as a scientist in the Neurobiology department before moving to the Corporate Development group to manage a team responsible for large technology transfer projects with strategic alliance partners. In 2003 he left Millennium to start his own consulting practice. He has published multiple research papers and reviews in Cell, Nature and other prestigious journals, as well as a book on apoptosis for Oxford University Press. He is a member of the Society for Neuroscience and the Project Management Institute and lives in Cambridge, MA.

For more information, please contact MDJ Consulting.